Legal and Policy Barriers to Telemedicine Prescribing of Controlled Analgesics for Chronic Non-cancer Pain: A Systematic Review
DOI:
https://doi.org/10.66687/jebmr.2.03.2026.35Resumen
Background: Telemedicine can reduce travel, geographic, mobility and specialist-access barriers in chronic non-cancer pain (CNCP), but prescribing controlled analgesics remotely is conditioned by overlapping controlled-substance law, patient-location licensure, prescribing standards, monitoring requirements, reimbursement and digital infrastructure. The evidence base is predominantly opioid-focused and has evolved rapidly since the COVID-19 public health emergency.
Methods: We conducted a systematic evidence review using PRISMA 2020 principles. On 17 August 2026, structured live searches restricted to PubMed-indexed record pages were performed using prespecified combinations of telemedicine/telehealth, CNCP/chronic pain/long-term opioid therapy, opioid/controlled analgesic, prescribing/monitoring, policy/licensure and implementation terms. Retrieval was supplemented by PMC/Europe PMC verification, citation chaining, related-title/PMID searches, and authoritative legal-policy searches of DEA, HHS, the Federal Register, Reginfo.gov and CDC. Fifty-eight unique empirical records were actually surfaced and screened; 34 underwent report-level assessment and 25 met eligibility criteria. No native subscription-database hit counts were estimated or fabricated. Methodological confidence was appraised using design-appropriate Mixed Methods Appraisal Tool domains, and findings were synthesized narratively because of substantial heterogeneity.
Results: The 25 included studies comprised randomized, quasi-experimental, cohort, claims-based, mixed-methods, qualitative and implementation studies, largely from the United States and Canada. Direct-to-patient telemedicine generally supported continuity and access but exposed limitations in video access, physical examination, remote monitoring and patient engagement. Provider-to-provider telementoring commonly improved clinician knowledge and, in several studies, reduced high-dose or otherwise potentially unsafe opioid prescribing. Recurrent barriers were regulatory instability; licensure based on patient location; variation in state prescribing rules; difficulty operationalizing toxicology, physical examination and other safeguards remotely; reimbursement and program sustainability; fragmented EHR, e-prescribing, pharmacy and laboratory workflows; and digital inequity. As of 17 August 2026, qualifying U.S. DEA-registered practitioners may prescribe Schedule II-V controlled substances by telemedicine without a prior in-person evaluation under the temporary federal flexibilities through 31 December 2026, subject to applicable federal and state requirements. DEA’s broader Special Registration rule remained at the final-rule stage rather than being a promulgated permanent replacement.
Conclusions: The principal barriers to tele-prescribing controlled analgesics for CNCP arise from fragmented and changing legal authority and from difficulty reproducing selected opioid-safety processes remotely, rather than from evidence that telemedicine is intrinsically unsafe. The most defensible policy model is hybrid and risk-stratified: preserve remote continuity for appropriately selected patients, integrate PDMP and other digital safeguards, maintain local pathways for examination and testing, simplify cross-jurisdiction practice, and replace temporary regulatory extensions with clear durable rules.
Referencias
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082-2097. doi:10.1016/S0140-6736(21)00393-7.
Vos T, Abajobir AA, Abbafati C, Abbas KM, Abate KH, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-1259.
Mathieson S, Wertheimer G, Maher CG, Lin CWC, McLachlan AJ, Buchbinder R, et al. What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta-regression of observational studies. J Intern Med. 2020;287(5):458-474. doi:10.1111/joim.13026.
Busse JW, Wang L, Kamaleldin M, Craigie S, Riva JJ, Montoya L, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. JAMA. 2018;320(23):2448-2460. doi:10.1001/jama.2018.18472.
Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial. JAMA. 2018;319(9):872-882. doi:10.1001/jama.2018.0899.
Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276-286. doi:10.7326/M14-2559.
Bohnert ASB, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315-1321. doi:10.1001/jama.2011.370.
Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain-United States, 2022. MMWR Recomm Rep. 2022;71(3):1-95.
Ryan Haight Online Pharmacy Consumer Protection Act of 2008, Pub L No. 110-425, 122 Stat 4820 (2008).
US Department of Health and Human Services. Prescribing controlled substances via telehealth [Internet]. Washington (DC): HHS; updated 2026 Jan 5 [cited 2026 Aug 17].
Drug Enforcement Administration; Department of Health and Human Services. Fourth temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications. Fed Regist. 2025;90:61301-61306. Effective 2026 Jan 1-Dec 31.
US Department of Health and Human Services. Licensing across state lines [Internet]. Washington (DC): HHS; updated 2025 Apr 30 [cited 2026 Aug 17].
Kannarkat JT, Kannarkat JT, Torous J. Rebalancing controlled substance regulations in telemedicine. JAMA Health Forum. 2023;4(10):e233251. doi:10.1001/jamahealthforum.2023.3251.
Shigekawa E, Fix M, Corbett G, Roby DH, Coffman J. The current state of telehealth evidence: a rapid review. Health Aff (Millwood). 2018;37(12):1975-1982. doi:10.1377/hlthaff.2018.05132.
Park J, Erikson C, Han X, Iyer P. Are state telehealth policies associated with the use of telehealth services among underserved populations? Health Aff (Millwood). 2018;37(12):2060-2068.
Eberly LA, Kallan MJ, Julien HM, Haynes N, Khatana SAM, Nathan AS, et al. Patient characteristics associated with telemedicine access for primary and specialty ambulatory care during the COVID-19 pandemic. JAMA Netw Open. 2020;3(12):e2031640. doi:10.1001/jamanetworkopen.2020.31640.
Patel SY, Mehrotra A, Huskamp HA, Uscher-Pines L, Ganguli I, Barnett ML. Trends in outpatient care delivery and telemedicine during the COVID-19 pandemic in the US. JAMA Intern Med. 2021;181(3):388-391.
Patel SY, Mehrotra A, Huskamp HA, Uscher-Pines L, Ganguli I, Barnett ML. Variation in telemedicine use and outpatient care during the COVID-19 pandemic in the United States. Health Aff (Millwood). 2021;40(2):349-358.
Mehrotra A, Bhatia RS, Snoswell CL. Paying for telemedicine after the pandemic. JAMA. 2021;325(5):431-432. doi:10.1001/jama.2020.25706.
Sandbrink F, Murphy JL, Johansson M, Olson JL, Edens E, Clinton-Lont J, et al. The use of opioids in the management of chronic pain: synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline. Ann Intern Med. 2023;176(3):388-397.
Agnoli A, Xing G, Tancredi DJ, Magnan E, Jerant A, Fenton JJ. Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids. JAMA. 2021;326(5):411-419. doi:10.1001/jama.2021.11013.
Fenton JJ, Magnan E, Tseregounis IE, Xing G, Agnoli AL, Tancredi DJ. Long-term risk of overdose or mental health crisis after opioid dose tapering. JAMA Netw Open. 2022;5(6):e2216726. doi:10.1001/jamanetworkopen.2022.16726.
Oliva EM, Bowe T, Manhapra A, Kertesz S, Hah JM, Henderson P, et al. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. BMJ. 2020;368:m283. doi:10.1136/bmj.m283.
Frank JW, Lovejoy TI, Becker WC, Morasco BJ, Koenig CJ, Hoffecker L, et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med. 2017;167(3):181-191. doi:10.7326/M17-0598.
Chou R, Deyo R, Friedly J, Skelly A, Hashimoto R, Weimer M, et al. Nonpharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline. Ann Intern Med. 2017;166(7):493-505. doi:10.7326/M16-2459.
Qaseem A, Wilt TJ, McLean RM, Forciea MA. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514-530. doi:10.7326/M16-2367.
Chou R, Deyo R, Friedly J, Skelly A, Weimer M, Fu R, et al. Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline. Ann Intern Med. 2017;166(7):480-492. doi:10.7326/M16-2458.
Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, et al. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356-2367. doi:10.1016/S0140-6736(18)30480-X.
Foster NE, Anema JR, Cherkin D, Chou R, Cohen SP, Gross DP, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391(10137):2368-2383. doi:10.1016/S0140-6736(18)30489-6.
Buchbinder R, van Tulder M, Oberg B, Costa LM, Woolf A, Schoene M, et al. Low back pain: a call for action. Lancet. 2018;391(10137):2384-2388. doi:10.1016/S0140-6736(18)30488-4.
Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Ann Intern Med. 2017;167(5):293-301.
Glanz JM, Binswanger IA, Shetterly SM, Narwaney KJ, Xu S. Association between opioid dose variability and opioid overdose among adults prescribed long-term opioid therapy. JAMA Netw Open. 2019;2(4):e192613. doi:10.1001/jamanetworkopen.2019.2613.
Mackey K, Anderson J, Bourne D, Chen E, Peterson K. Benefits and harms of long-term opioid dose reduction or discontinuation in patients with chronic pain: a rapid review. J Gen Intern Med. 2020;35(Suppl 3):935-944.
Huskamp HA, Busch AB, Souza J, Uscher-Pines L, Rose S, Wilcock A, et al. How is telemedicine being used in opioid and other substance use disorder treatment? Health Aff (Millwood). 2018;37(12):1940-1947.
Hailu R, Mehrotra A, Huskamp HA, Busch AB, Barnett ML. Telemedicine use and quality of opioid use disorder treatment in the US during the COVID-19 pandemic. JAMA Netw Open. 2023;6(1):e2252381.
Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, Chou R. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 2014;160(1):38-47.
Tauben DJ, Langford DJ, Sturgeon JA, Rundell SD, Towle C, Bockman C, Nicholas M. Optimizing telehealth pain care after COVID-19. Pain. 2020;161(11):2437-2445. doi:10.1097/j.pain.0000000000002048.
DeBar LL, Mayhew M, Wellman RD, Balderson BH, Dickerson JF, Elder CR, et al. Telehealth and online cognitive behavioral therapy-based treatments for high-impact chronic pain: a randomized clinical trial. JAMA. 2025;334(7):592-605. doi:10.1001/jama.2025.11178.
Anderson D, Zlateva I, Davis B, Bifulco L, Giannotti T, Coman E, Spegman D. Improving pain care with Project ECHO in community health centers. Pain Med. 2017;18(10):1882-1889. doi:10.1093/pm/pnx187.
Ball S, Wilson B, Ober S, Mchaourab A. SCAN-ECHO for pain management: implementing a regional telementoring training for primary care providers. Pain Med. 2018;19(2):262-268. doi:10.1093/pm/pnx122.
Furlan AD, Zhao J, Voth J, Hassan S, Dubin R, Stinson JN, et al. Evaluation of an innovative tele-education intervention in chronic pain management for primary care clinicians practicing in underserved areas. J Telemed Telecare. 2019;25(8):484-492. doi:10.1177/1357633X18782090.
Katzman JG, Qualls CR, Satterfield WA, Kistin M, Hofmann K, Greenberg N, et al. Army and Navy ECHO Pain telementoring improves clinician opioid prescribing for military patients: an observational cohort study. J Gen Intern Med. 2019;34(3):387-395. doi:10.1007/s11606-018-4710-5.
Diaz S, Zhao J, Cronin S, Jaglal S, Bombardier C, Furlan AD. Changes in opioid prescribing behaviors among family physicians who participated in a weekly tele-mentoring program. J Clin Med. 2020;9(1):14. doi:10.3390/jcm9010014.
Eaton LH, Godfrey DS, Langford DJ, Rue T, Tauben DJ, Doorenbos AZ. Telementoring for improving primary care provider knowledge and competence in managing chronic pain: a randomised controlled trial. J Telemed Telecare. 2020;26(1-2):21-27. doi:10.1177/1357633X18802978.
Flynn D, Doorenbos AZ, Steffen A, McQuinn H, Langford DJ. Pain management telementoring, long-term opioid prescribing, and patient-reported outcomes. Pain Med. 2020;21(2):266-273. doi:10.1093/pm/pnz338.
Zhao J, Salemohamed N, Stinson J, Carlin L, Seto E, Webster F, et al. Health care providers’ experiences and perceptions participating in a chronic pain telementoring education program: a qualitative study. Can J Pain. 2020;4(1):111-121. doi:10.1080/24740527.2020.1749003.
Glynn LH, Chen JA, Dawson TC, Gelman H, Zeliadt SB. Bringing chronic-pain care to rural veterans: a telehealth pilot program description. Psychol Serv. 2021;18(3):310-318. doi:10.1037/ser0000408.
Gersch WD, Delate T, Bergquist KM, Smith K. Clinical effectiveness of an outpatient multidisciplinary chronic pain management telementoring service. Clin J Pain. 2021;37(10):740-746. doi:10.1097/AJP.0000000000000967.
Chen JA, DeFaccio RJ, Gelman H, Thomas ER, Indresano JA, Dawson TC, et al. Telehealth and rural-urban differences in receipt of pain care in the Veterans Health Administration. Pain Med. 2022;23(3):466-474. doi:10.1093/pm/pnab194.
Rikin S, Perez HR, Zhang C, Khalid L, Groeger J, Deng Y, et al. Changes in outpatient opioid prescribing during the COVID-19 pandemic: an interrupted time series analysis. J Prim Care Community Health. 2022;13:21501319221076926. doi:10.1177/21501319221076926.
Cooke A, Castellanos S, Enriquez C, Olsen P, Miaskowski C, Kushel M, et al. Telehealth for management of chronic non-cancer pain and opioid use disorder in safety net primary care. BMC Health Serv Res. 2023;23:325. doi:10.1186/s12913-023-09330-w.
Hayes CJ, Gannon MA, Woodward EN, Long CR, George M, Ray-Griffith S, et al. Implementation and preliminary effectiveness of a multidisciplinary telemedicine pilot initiative for patients with chronic non-cancer pain in rural and underserved areas at a major academic medical center. J Pain Res. 2023;16:55-69. doi:10.2147/JPR.S383212.
Rogers DG, Frank JW, Wesolowicz DM, Nolan C, Schroeder A, Falker C, et al. Video-telecare collaborative pain management during COVID-19: a single-arm feasibility study. BMC Prim Care. 2023;24:134. doi:10.1186/s12875-023-02052-2.
Kaseweter K, Nazemi M, Gregoire N, Louw WF, Walsh Z, Holtzman S. Physician perspectives on chronic pain management: barriers and the use of eHealth in the COVID-19 era. BMC Health Serv Res. 2023;23(1):1131. doi:10.1186/s12913-023-10157-8.
Gray E, Erickson M, Bindler R, Eti DU, Wilson M. Experiencing COMFORT: perceptions of virtually-delivered nonpharmacologic therapies in adults prescribed opioids for chronic pain. Pain Manag Nurs. 2023;24(4):469-476. doi:10.1016/j.pmn.2023.04.002.
Flynn DM, Mathew A, McQuinn H, Ransom JC, Steffen AD, Doorenbos AZ. Effectiveness of telementoring in improving provider knowledge, attitudes, and perceived competence in managing chronic pain: a mixed methods study. Mil Med. 2023;188(5-6):1192-1198. doi:10.1093/milmed/usac005.
McHugh MC, Fowler CA, Philbin S, Schneider T, Ballistrea LM, Klanchar SA, et al. Qualitative evaluation informs the implementation of a telehealth program to manage chronic pain. J Pain. 2024;25(7):104493. doi:10.1016/j.jpain.2024.02.007.
Ogundele OB, Song X, Rao P, Greever-Rice T, Boren SA, Edison K, et al. Claims data analysis of provider-to-provider tele-mentoring program impact on opioid prescribing in Missouri. J Opioid Manag. 2024;20(2):133-147. doi:10.5055/jom.0825.
Edwards KA, Dildine TC, You DS, Herrick AM, Darnall BD, Mackey SC, Ziadni MS. Zoom-delivered Empowered Relief for chronic pain: observational longitudinal pilot study exploring feasibility and pain-related outcomes in patients on long-term opioids. JMIR Form Res. 2025;9:e68292. doi:10.2196/68292.
Friedman SA, Lewandowski M, Patterson DG, Snyder P, Sangoleye D, Jorgensen TC, et al. A short-duration telementoring pain management programme for Medicaid: impact on clinician outcomes. Health Educ Res. 2025;40(3):cyaf019. doi:10.1093/her/cyaf019.
Clark HY, Kromelow J, Josefsberg J, Schultz SK, Brose WG. Weekly opioid shared medical prescribing appointments to remediate issues of chronic pain patient adherence, aberrance, and noncompliance. J Opioid Manag. 2025;21(5):389-399. doi:10.5055/jom.0944.
Jorgenson DJ, Halpape K, Marwah R, Siton M. Impact of virtual case conferences between primary care clinicians and an interdisciplinary chronic pain clinic. Can Fam Physician. 2026;72(6):e208-e213. doi:10.46747/cfp.7206e208.
Ziadni MS, Herrick A, Sturgeon JA, Salmasi V, Darnall BD, Mackey S. Single-session, virtual, pain relief skills class for adults with chronic pain on long-term opioids: a randomized controlled trial. J Pain. 2026;44:106286. doi:10.1016/j.jpain.2026.106286.
Office of Information and Regulatory Affairs. Special Registrations for Telemedicine and Limited State Telemedicine Registrations. RIN 1117-AB40 [Internet]. Washington (DC): Office of Management and Budget; 2026 Unified Agenda [cited 2026 Aug 17].
US Department of Health and Human Services. Licensure compacts [Internet]. Washington (DC): HHS; updated 2025 Dec 10 [cited 2026 Aug 17].
US Department of Health and Human Services. Build a sustainable telehealth practice [Internet]. Washington (DC): HHS; 2025 [cited 2026 Aug 17].
Hong QN, Fabregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, et al. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Educ Inf. 2018;34(4):285-291.
